LianBio (LIAN) Competitors $0.06 +0.00 (+5.83%) As of 10/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendFDA EventsSEC FilingsTrendsBuy This Stock LIAN vs. GNPX, IMA, SONN, LNAI, CVKD, AKTX, DARE, PASG, ENLV, and LPTXShould you be buying LianBio stock or one of its competitors? The main competitors of LianBio include GENPREX (GNPX), ImageneBio (IMA), Sonnet BioTherapeutics (SONN), Lunai Bioworks (LNAI), Cadrenal Therapeutics (CVKD), Akari Therapeutics (AKTX), Dare Bioscience (DARE), Passage Bio (PASG), Enlivex Therapeutics (ENLV), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. LianBio vs. Its Competitors GENPREX ImageneBio Sonnet BioTherapeutics Lunai Bioworks Cadrenal Therapeutics Akari Therapeutics Dare Bioscience Passage Bio Enlivex Therapeutics Leap Therapeutics LianBio (NASDAQ:LIAN) and GENPREX (NASDAQ:GNPX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Is LIAN or GNPX more profitable? LianBio's return on equity of -33.17% beat GENPREX's return on equity.Company Net Margins Return on Equity Return on Assets LianBioN/A -33.17% -30.19% GENPREX N/A -809.27%-386.95% Which has more volatility and risk, LIAN or GNPX? LianBio has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, GENPREX has a beta of -0.71, suggesting that its share price is 171% less volatile than the S&P 500. Do institutionals & insiders have more ownership in LIAN or GNPX? 74.8% of LianBio shares are owned by institutional investors. Comparatively, 14.1% of GENPREX shares are owned by institutional investors. 7.6% of LianBio shares are owned by company insiders. Comparatively, 0.4% of GENPREX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Do analysts recommend LIAN or GNPX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LianBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00GENPREX 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has higher valuation and earnings, LIAN or GNPX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianBioN/AN/A-$110.29M-$0.81-0.08GENPREXN/AN/A-$21.11MN/AN/A Does the media favor LIAN or GNPX? In the previous week, GENPREX had 5 more articles in the media than LianBio. MarketBeat recorded 5 mentions for GENPREX and 0 mentions for LianBio. GENPREX's average media sentiment score of 0.38 beat LianBio's score of 0.00 indicating that GENPREX is being referred to more favorably in the news media. Company Overall Sentiment LianBio Neutral GENPREX Neutral SummaryLianBio beats GENPREX on 5 of the 9 factors compared between the two stocks. Get LianBio News Delivered to You Automatically Sign up to receive the latest news and ratings for LIAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIAN vs. The Competition Export to ExcelMetricLianBioBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.86M$225.33M$6.15B$10.56BDividend YieldN/A3.80%5.72%4.84%P/E Ratio-0.08101.1685.7027.05Price / SalesN/A5,957.53612.92132.40Price / CashN/A13.1925.8230.35Price / Book0.0297.5312.226.58Net Income-$110.29M-$90.99M$3.33B$276.84M7 Day PerformanceN/A1.13%1.17%1.93%1 Month PerformanceN/A5.79%6.85%2.19%1 Year PerformanceN/A563.75%58.93%34.62% LianBio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIANLianBioN/A$0.06+5.8%N/A-78.5%$6.86MN/A-0.08110Gap UpGNPXGENPREX2.1264 of 5 stars$0.71+182.8%N/A-13.4%$30.63MN/A0.0020News CoverageAnalyst UpgradeShort Interest ↓Gap DownHigh Trading VolumeIMAImageneBio2.8557 of 5 stars$7.63-0.1%$35.50+365.3%-63.3%$30.56M$3.50M-0.9970Negative NewsShort Interest ↑SONNSonnet BioTherapeutics1.6952 of 5 stars$4.37+1.3%$20.00+358.2%-41.9%$29.81M$20K0.0010News CoverageLNAILunai BioworksN/A$1.25+2.5%N/AN/A$28.98MN/A-0.1620News CoverageCVKDCadrenal Therapeutics2.9148 of 5 stars$14.04-0.4%$32.00+127.9%-21.0%$28.74MN/A-1.584AKTXAkari Therapeutics2.6374 of 5 stars$0.86-12.7%$3.30+285.5%-66.2%$27.92MN/A0.009News CoverageShort Interest ↑Gap UpDAREDare Bioscience2.5246 of 5 stars$2.07+0.2%$10.00+384.3%-45.6%$27.89M$10K-0.9730Positive NewsGap UpPASGPassage Bio3.0949 of 5 stars$8.72+0.3%$75.67+767.7%-30.4%$27.83MN/A-0.48130ENLVEnlivex Therapeutics2.6817 of 5 stars$1.15+3.2%$10.00+773.4%-30.3%$27.81MN/A-1.9770News CoverageGap DownLPTXLeap Therapeutics2.8537 of 5 stars$0.65+4.2%$3.38+421.6%-79.4%$26.81MN/A-0.4140News CoveragePositive NewsAnalyst DowngradeShort Interest ↓Gap Up Related Companies and Tools Related Companies GNPX Alternatives IMA Alternatives SONN Alternatives LNAI Alternatives CVKD Alternatives AKTX Alternatives DARE Alternatives PASG Alternatives ENLV Alternatives LPTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIAN) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIAN Stock Alerts